Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and Hypertension

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

December 16, 2023

Study Completion Date

December 16, 2023

Conditions
Diabetes MellitusChronic Obstructive Pulmonary DiseaseCongestive Heart FailureMyasthenia GravisHypertension
Interventions
DEVICE

Medlink

The 10 Patients enrolled in this arm tested the ue of Medlink in Measuring and reporting their Physiological Paramters in Oder to remotely obtain access to health care for the following diseases: Myasthenia Gravis, Hypertension, Chronic Heart Failure, Diabetes Mellitus, and Chronic Obstruction Pulmonary Disorder.

Trial Locations (1)

EC1V 2NX

Olawuyi Racett Nigeria Ltd., London

All Listed Sponsors
lead

Olawuyi Racett Nigeria Ltd

INDUSTRY